| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 1e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |